Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Product Stability01:16

Drug Product Stability

218
The long-term stability of drug products is critical to ensuring their quality, safety, and effectiveness over time. Stability directly influences a product's ability to maintain its intended characteristics, ensuring it performs as expected during its intended shelf life. Key attributes such as drug potency, impurities, dissolution, and other physicochemical measures of performance are tested to assess stability. These parameters indicate how well the product retains its quality over time and...
218
Drug Dissolution: Requirements and Profile Comparison01:14

Drug Dissolution: Requirements and Profile Comparison

220
The acceptance criteria for dissolution profile data are anchored in Q values, representing the percentage of drug dissolved within a specified period. This assessment unfolds in three stages:First Stage: The test passes if all six drug dosage units are equal to or greater than Q plus 5%; otherwise, the sample proceeds to the second stage.Second Stage: The average of twelve units must be equal to or greater than Q, with no unit falling below Q - 15% to pass; if not, it progresses to the final...
220
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

139
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
139
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

168
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
168
In Vitro Drug Dissolution: Compendial Testing Models II01:09

In Vitro Drug Dissolution: Compendial Testing Models II

224
Various dissolution methods are utilized to assess a drug’s dissolution rate, including the flow-through cell, paddle-over-disk, cylinder, and reciprocating disk methods.The flow-through cell apparatus (USP (United States Pharmacopeia) method 4) comprises a reservoir for the dissolution medium and a pump that propels the medium through the cell containing the test sample. This method is crucial for assessing modified-release dosage forms with minimally soluble active ingredients,...
224
In Vitro Drug Dissolution: Compendial Testing Models I01:13

In Vitro Drug Dissolution: Compendial Testing Models I

209
Compendial dissolution methods are standardized procedures defined by pharmacopeias to evaluate the rate at which a drug dissolves in a specific medium. These methods ensure batch-to-batch consistency, enable quality control, and support the prediction of drug bioavailability. They are critical for both immediate and modified-release drug products.The apparatuses used for dissolution testing differ in their design and mechanical function, but all aim to simulate the physiological environment of...
209

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Manganese-Catalyzed Formate Synthesis via Coupled Methanol Dehydrogenation and Bicarbonate Reduction.

Inorganic chemistry·2026
Same author

Optimization of Fe(III)-based negative electrodes for lithium-ion batteries: probing electrochemical performance and stability characteristics.

Dalton transactions (Cambridge, England : 2003)·2026
Same author

Enhancing the therapeutic efficacy of curcumin in topical applications through nanoformulations.

Natural product research·2026
Same author

A review on recent advances in lipid-based drug delivery systems for tuberculosis.

Iranian journal of basic medical sciences·2026
Same author

Application of Stage 3a Heightened Monitoring to Close Process Knowledge Gaps of Legacy Injectable Products: A Commercial Scale Case Study.

PDA journal of pharmaceutical science and technology·2026
Same author

DRDarkNet: a hybrid deep feature engineering model for accurate autopsy image classification.

International journal of legal medicine·2026

Related Experiment Video

Updated: Jan 10, 2026

A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients
11:27

A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients

Published on: August 9, 2022

2.4K

Variability Assessment Methods for Lyophilized Drug Product, A Case Study.

Ajay Babu Pazhayattil1, Marzena Ingram2, Prasanna Sagar3

  • 1cGMPWorld, Toronto, ON, Canada ajpazha@gmail.com.

PDA Journal of Pharmaceutical Science and Technology
|November 24, 2025
PubMed
Summary

This study introduces a statistically sound, risk-based sampling method for lyophilization process verification. It ensures injectable drug product quality by assessing and controlling variability during continued process verification.

Keywords:
CPVCQAsLyophilizationPPQQbDScale-UpStage 3aStatisticsVariability

More Related Videos

Mass Spectrometric Approaches to Study Protein Structure and Interactions in Lyophilized Powders
11:14

Mass Spectrometric Approaches to Study Protein Structure and Interactions in Lyophilized Powders

Published on: April 14, 2015

16.7K
Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface
07:00

Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface

Published on: August 11, 2017

8.6K

Related Experiment Videos

Last Updated: Jan 10, 2026

A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients
11:27

A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients

Published on: August 9, 2022

2.4K
Mass Spectrometric Approaches to Study Protein Structure and Interactions in Lyophilized Powders
11:14

Mass Spectrometric Approaches to Study Protein Structure and Interactions in Lyophilized Powders

Published on: April 14, 2015

16.7K
Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface
07:00

Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface

Published on: August 11, 2017

8.6K

Area of Science:

  • Pharmaceutical Sciences
  • Chemical Engineering
  • Process Analytical Technology

Background:

  • Lyophilization is crucial for injectable drug product stability, involving complex stages like freezing and drying.
  • Ensuring product quality and consistency requires robust statistical and risk-based methodologies for process variability assessment.
  • Quality by Design (QbD) principles are vital for lyophilization process development.

Purpose of the Study:

  • To present a risk-based, statistically sound sampling methodology for assessing variability in lyophilized drug products.
  • To enable estimation of future batch performance for critical quality attributes.
  • To support regulatory compliance and enhance process understanding for continuous improvement.

Main Methods:

  • Development of strategically designed sampling plans for representative data collection from lyophilizer shelves.
  • Integration of variance analysis, capability indices, and probability for comprehensive variability assessment.
  • Application of a risk-based framework for Continued Process Verification (Stage 3a) of Process Validation.

Main Results:

  • The methodology provides a thorough understanding of intra-batch (within-shelf, between-shelf) and inter-batch variability.
  • It enables accurate estimation of future batch performance concerning water content, assay, pH, and impurities.
  • A case study demonstrates the successful application of the approach in a lyophilization process.

Conclusions:

  • Statistically rigorous sampling plans and data analysis are essential for effective lyophilization process control.
  • The risk-based Stage 3a framework facilitates post-commercialization variability assessment and process improvement.
  • This methodology enhances process understanding, leading to tighter control and improved product quality for injectable drugs.